ReviewMikrochimica acta2026
Broad-spectrum aptamers: recent advances in selection strategies, structural mechanisms, and biosensing applications.
Review in Mikrochimica acta, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Broad-spectrum aptamers are single-stranded DNA or RNA molecules capable of recognizing multiple structurally or functionally related targets through adaptable molecular interactions. The increasing demand for rapid, efficient, and multi-analyte detection in complex analytical systems has exposed the limitations of conventional single-target aptamers, particularly their dependence on multiple individual recognition elements and their limited adaptability toward related analytes. This review systematically summarizes recent advances in broad-spectrum aptamers from the perspectives of target selection, structural engineering, and biosensing applications, with particular emphasis on the transition from empirical multi-target selection toward rational and mechanism-guided design. We first examine major selection strategies, including mixed-target, parallel and sequential, alternating-target, combined selection, and emerging interdisciplinary approaches, highlighting how selection pressure and target configuration influence recognition breadth, affinity, and selectivity. We then discuss structural engineering strategies, including secondary-structure regulation, chemical modification, sequence truncation and mutation, molecular simulation, and structural analysis-guided optimization, with emphasis on the molecular mechanisms underlying conformational adaptability and cross-target recognition. Recent advances in electrochemical, fluorescence, colorimetric, surface-enhanced Raman scattering, chemiluminescent, and multimodal aptasensors are further summarized, together with emerging approaches such as sensor arrays and multi-signal calibration for improving quantitative reliability in multi-analyte analysis. Finally, the major challenges and future opportunities are discussed, particularly the need to balance recognition breadth, affinity uniformity, structural adaptability, and quantitative accuracy. The integration of rational SELEX design, structural characterization, computational intelligence, nanotechnology, and miniaturized sensing platforms is expected to facilitate the development of robust, portable, and quantitatively reliable broad-spectrum aptasensors for applications in food safety, environmental monitoring, pharmaceutical analysis, and clinical diagnostics.
Indexed as
Identifiers
42911442What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.